Calloway Laboratories
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Calloway Laboratories - overview
Established
2003
Location
Woburn, MA, US
Primary Industry
Healthcare
About
Calloway Laboratories provides technology solutions focused on enhancing operational efficiency through innovative software platforms for data analytics, process automation, and customer relationship management. Founded in 2003 and headquartered in Woburn, US, Calloway Laboratories is a technology firm specializing in operational efficiency solutions. The company has engaged in two investment deals to date. Details regarding the founder's past ventures are not available.
Calloway Labs specializes in innovative technology solutions aimed at enhancing operational efficiency across various industries. Their core offerings include advanced software platforms designed for data analytics, process automation, and customer relationship management. These tools address specific use cases such as streamlining workflows, improving data accuracy, and enhancing client engagement. Serving a diverse clientele that includes small to medium-sized enterprises and larger corporations, their products are marketed primarily in North America and Europe, particularly in sectors such as retail, finance, and healthcare.
Calloway Labs generates revenue through a structured subscription model, allowing clients to access their software solutions on a recurring basis. Their transactions typically involve B2B partnerships, with various tiers of service tailored to organizational needs. The flagship products are offered under competitive pricing plans that cater to both large enterprises and smaller businesses, ensuring consistent cash flow and fostering long-term client relationships. Calloway Laboratories is focused on expanding its product line with new software solutions aimed at further enhancing operational processes.
Specific release dates for these products remain unannounced. The company is planning to enter new markets in Asia and Latin America by the end of 2024, leveraging recent funding to support market research and development initiatives. Notably, Ampersand Capital Partners no longer holds a stake in Calloway Laboratories.
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Website
www.callowaylabs.com
Total Amount Raised
Subscriber access only
Calloway Laboratories - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Calloway Laboratories | - | ||||||||
| Unspecified Exit | Completed | Calloway Laboratories | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.